DTIL — PRECISION BIOSCIENCES INC
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1357874 ·
Last close
$7.05
Market Cap
$196.95M
52W High
$11.29
52W Low
$3.53
ADV30
383,053
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -20,428,000 | -7,586,000 | 120,376,000 | 81,698,000 | 68,601,000 |
| Jun 2026 | 0 | — | -19,161,000 | -32,652,000 | 125,920,000 | 86,076,000 | 80,627,000 |
| Mar 2026 | 10,838,000 | — | -9,075,000 | -18,441,000 | 143,891,000 | 99,370,000 | 67,790,000 |
| Dec 2025 | 34,204,000 | — | 12,508,000 | 20,133,000 | 154,416,000 | 110,823,000 | 62,168,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-51,761,000
Investing CF
$-638,000
Financing CF
$89,221,000
CapEx
$-704,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.24
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-586,867,000
Inventory
—
Receivables
$0
ST Investments
$148,000
EBIT TTM
$-38,165,000
Pretax Income TTM
$-39,431,000
Interest Exp TTM
$1,266,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$45,042,000
EBITDA
$-35,037,000
Free Cash Flow
$-18,004,750
Enterprise Value
$241,992,624
Total Cash
$81,846,000
Total Debt
$27,720,000
Shares Out
27,935,719
Trailing EPS
$0.25
Book Value
$1.86
ROE
-115.3%
ROA
-21.1%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 34,264,000 | -52,148,000 | -45,724,000 | 154,416,000 | 62,168,000 | 92,248,000 | -65,843,000 |
| Dec 2024 | 68,696,000 | -26,162,000 | 7,167,000 | 136,388,000 | 79,995,000 | 56,393,000 | -58,445,000 |
| Dec 2023 | 48,727,000 | -43,736,000 | -61,319,000 | 159,781,000 | 140,920,000 | 18,861,000 | -84,114,000 |
| Dec 2022 | 25,098,000 | -62,308,000 | -111,637,000 | 238,169,000 | 177,736,000 | 60,433,000 | -45,753,000 |
TTM Snapshot
Revenues TTM
$45,055,000
NetIncome TTM
$-52,732,000
OpCashFlow TTM
—
Assets (Latest)
$125,920,000
Forward EPS
$-1.86
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $7.10 · call volume: 18 · put volume: 48
Expected Move to 2026-12-18:
±$2.37
(33.38%) —
implied range
$4.73 –
$9.47
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IKT | Inhibikase Therapeutics, Inc. | $193.57M | $1.38 | — |
| CGEN | COMPUGEN LTD | $191.34M | $2.02 | — |
| ARTV | Artiva Biotherapeutics, Inc. | $190.81M | $3.86 | — |
| LCTX | Lineage Cell Therapeutics, Inc. | $206.36M | $0.82 | — |
| PALI | PALISADE BIO, INC. | $181.07M | $1.01 | — |
News headlines (Yahoo Finance, 1h cache)
Precision BioSciences prices 10.24M shares at $7.75 in underwritten offering
2026-11-05 21:27 · Yahoo
Precision BioSciences Announces Pricing of $125 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
2026-11-05 12:10 · Yahoo
Precision BioSciences Announces Late-Breaking PBGENE-HBV Data at AASLD The Liver Meeting® 2026 Further Demonstrating cccDNA Elimination and Potential to Drive Viral Cure
2026-11-05 12:00 · Yahoo
Precision BioSciences Announces Positive DSMB Safety Review Supporting Additional PBGENE-DMD Dosing in Phase 1/2 FUNCTION-DMD Study
2026-11-05 12:00 · Yahoo
Precision BioSciences: Q3 Earnings Snapshot
2026-11-03 12:11 · Yahoo
Precision BioSciences Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-03 12:01 · Yahoo
Precision BioSciences to Report Third Quarter 2026 Financial Results on November 3, 2026
2026-10-29 11:01 · Yahoo
Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026
2026-10-08 11:01 · Yahoo
Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study
2026-08-24 10:01 · Yahoo
Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-08-06 11:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.